We detected decreased CD68+ macrophages in both the liver and spleen in VCR/BLZ945 combination‐treated mice when compared with the PBS group or VCR single‐treated mice (Figure 6D,E), indicating that VCR/BLZ945 treatment significantly reduced the abundance of macrophages in tumour‐bearing mice. Here, CD68 is linked to neoplasm.